台股 » 個股 » 生展 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生展

(8279)
  • 股價
    161.0
  • 漲跌
    ▲1.0
  • 漲幅
    +0.63%
  • 成交量
    8
  • 產業
    上櫃 生技醫療類股
  • 67人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生展 (8279)籌碼相關-永豐金-三重 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-三重 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/2300.001152.00152.00-111-8.98%
2024/05/211149.5000.00153.001109.19%
2024/05/1000.001151.50155.00-110-9.52%
2024/05/071149.5000.00150.001109.29%
2024/03/0700.001153.00151.00-19-10.89%
2024/03/061151.5000.00151.501811.15%
2024/02/271151.5000.00152.001911.01%
2024/02/2600.001154.00154.00-19-10.95%
2024/02/051149.5000.00148.001811.24%
2024/01/2500.001152.00152.00-19-10.45%
2024/01/221150.5000.00150.501910.70%
2024/01/1700.001153.50152.00-19-10.62%
2023/12/291152.5000.00152.001109.46%
2023/03/0600.003180.00180.00-360-5.00%
2023/03/033172.5000.00171.003585.15%
2022/11/172149.002148.50149.500740.00%
2022/08/3000.002175.25175.50-291-2.18%
2022/08/291178.5000.00178.001911.10%
2022/08/262175.501174.50174.501891.12%
2021/06/1100.001104.50106.00-138-2.57%
2021/05/251101.5000.00102.001412.41%
2021/03/1500.001114.00113.00-152-1.92%
2021/02/231108.5000.00109.501511.96%
2021/01/2000.001102.00100.50-141-2.43%
2020/12/251108.5000.00108.001283.49%
2020/08/2100.001126.00129.50-1123-0.81%
2020/08/191136.5000.00135.0011150.87%
2020/03/101113.001110.00110.000740.00%
2019/12/1800.001120.50119.50-168-1.46%
2019/12/171118.0000.00121.001701.42%
2019/09/1600.001141.50141.50-1113-0.88%
2019/09/1000.001141.50142.00-1113-0.88%
2019/09/0500.006144.00143.50-6113-5.27%
2019/08/2900.001143.50148.00-1113-0.88%
2019/08/1500.001134.50137.00-1104-0.95%
2019/08/142139.0000.00137.0021041.91%
2019/08/131136.5000.00136.5011030.97%
2019/08/011150.5000.00153.001941.06%
2019/07/304147.755150.00151.00-192-1.08%
2019/07/221150.0000.00154.001811.23%
2019/07/1900.004149.00148.00-478-5.09%
2019/07/173153.0000.00153.503734.06%
2019/07/1600.001153.00154.50-172-1.38%
2019/07/151151.006149.67149.00-568-7.35%
2019/07/081143.5000.00141.001591.68%
2019/07/021136.0000.00139.001551.79%
2019/07/015136.2000.00139.505549.19%
2019/06/181126.0000.00126.501472.09%
2019/05/161119.5000.00120.001671.49%
2019/05/101124.0000.00124.001661.51%
2019/05/071127.5000.00131.001671.48%
2019/05/061126.5000.00126.501661.51%
2019/05/021125.0000.00127.001631.57%
2019/02/1800.002105.00105.50-224-8.15%
2019/01/292105.5000.00105.502248.11%
2018/10/1100.00184.1085.50-155-1.81%
2018/10/0900.00191.6092.40-153-1.86%
2018/10/042102.5000.00100.502523.82%
2018/07/1100.001122.00121.50-1192-0.52%
2018/07/091121.0000.00123.5011970.51%
2018/06/1500.004148.00149.00-4282-1.42%
2018/06/1400.001146.50146.00-1281-0.35%
2018/06/012150.5000.00152.0022950.68%
2018/05/233148.6700.00148.5033070.98%
2018/05/1400.002155.00155.00-2356-0.56%
2018/05/092156.0000.00153.0023560.56%
2018/05/0700.001156.50156.50-1361-0.28%
2018/05/031163.0000.00163.0013670.27%
2018/04/232179.502177.00172.0003640.00%
2018/03/302155.502154.50151.0002820.00%
2018/03/2100.001144.00143.00-1267-0.37%
2018/03/0200.001141.50141.00-1313-0.32%
2018/02/211130.0000.00130.5013110.32%
2018/02/071164.5000.00165.0012980.34%
2018/02/0200.003181.00178.50-3321-0.93%
2018/02/013184.331184.00182.5023230.62%
2018/01/3000.003183.67177.00-3324-0.93%
2018/01/293182.0000.00183.0033250.92%
2018/01/261181.0000.00179.5013210.31%
2018/01/0900.003172.00172.50-3281-1.07%
2018/01/083168.0000.00168.5032761.08%
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
〈聯合再生展望〉洪傳獻:TOPCon技術明年成主流 獲利表現佳Anue鉅亨-2023/10/16
生展 相關文章